Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1158/1538-7445.am2018-lb-011

Abstract LB-011: Novel nano-formulation of paclitaxel for pancreatic cancer therapy

..., Subhash C. Chauhan
49
Cancer Research11.20
Volume: 78, Issue: 13_Supplement, Pages: LB - 011
Published: Jul 1, 2018
Abstract
Pancreatic cancer (PanCa) is one of the leading causes of cancer-related mortality in the United States due to very limited therapeutic options. Thus, there is an urgent need to develop novel therapeutic strategies for the management of this disease. Paclitaxel (PTX), a natural product derived from the Pacific Yew tree, is an agent typically used in combination therapy for PanCa. Currently, PTX nanoparticles (Abraxane®) along with gemcitabine...
Paper Fields
Paper Details
Title
Abstract LB-011: Novel nano-formulation of paclitaxel for pancreatic cancer therapy
DOI
doi.org/10.1158/1538-7445.am2018-lb-011
Published Date
Jul 1, 2018
Journal
Cancer Research
Volume
78
Issue
13_Supplement
Pages
LB - 011
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.